The Lower Limit of Reference of Urinary Albumin/Creatinine Ratio and the Risk of Chronic Kidney Disease Progression in Patients With Type 2 Diabetes Mellitus

被引:6
|
作者
Tang, Wei-Hua [1 ,2 ]
Hung, Wei-Chin [3 ,4 ]
Wang, Chao-Ping [3 ,5 ]
Wu, Cheng-Ching [3 ,4 ]
Hsuan, Chin-Feng [3 ,4 ,6 ]
Yu, Teng-Hung [3 ,4 ]
Hsu, Chia-Chang [7 ,8 ]
Cheng, Ya-Ai [9 ]
Chung, Fu-Mei [3 ]
Lee, Yau-Jiunn [10 ]
Lu, Yung-Chuan [5 ,11 ]
机构
[1] Taipei Vet Gen Hosp, Dept Internal Med, Div Cardiol, Yuli Branch, Hualien, Taiwan
[2] Natl Yang Ming Chiao Tung Univ, Fac Med, Sch Med, Taipei, Taiwan
[3] E Da Hosp, Dept Internal Med, Div Cardiol, Kaohsiung, Taiwan
[4] I Shou Univ, Coll Med, Sch Med Int Students, Kaohsiung, Taiwan
[5] I Shou Univ, Coll Med, Sch Med Int Students, Kaohsiung, Taiwan
[6] E Da Dachang Hosp, Dept Internal Med, Div Cardiol, Kaohsiung, Taiwan
[7] E Da Hosp, Dept Internal Med, Div Gastroenterol & Hepatol, Kaohsiung, Taiwan
[8] I Shou Univ, Coll Med, Sch Chinese Med Post Baccalaureate, Kaohsiung, Taiwan
[9] I Shou Univ, Coll Med, Dept Hlth Care Adm, Kaohsiung, Taiwan
[10] Lees Endocrinol Clin, Pingtung, Taiwan
[11] E Da Hosp, Dept Internal Med, Div Endocrinol & Metab, Kaohsiung, Taiwan
来源
FRONTIERS IN ENDOCRINOLOGY | 2022年 / 13卷
关键词
Type 2 diabetes mellitus; low-grade albuminuria; risk; chronic kidney disease; progression; STAGE RENAL-DISEASE; P-CRESYLSULFATE; MICROALBUMINURIA; MORTALITY; ASSOCIATIONS; HYPERTENSION; INDIVIDUALS; MANAGEMENT; GENDER; HEALTH;
D O I
10.3389/fendo.2022.858267
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
A urine albumin/creatinine ratio (UACR) <30 mg/g is considered to be normal, while increased risk of incident hypertension and cardiovascular disease mortality in subjects with high normal UACR level had been observed. However, a mild elevated but normal UACR level was associated with the risk of initiating chronic kidney disease (CKD) is uncertain. We investigated whether higher normal UACR is associated with the risk of developing CKD. A total of 4821 subjects with type 2 diabetes mellitus (T2DM), an estimated glomerular filtration rate >60 ml/min/1.73 m(2) and UACR <30 mg/g enrolled in a diabetes disease management program between 2006 and 2020 were studied. The optimal cutoff point for baseline UACR as a predictor for progression to CKD according to the 2012 KDIGO definition was calculated using receiving operating characteristic curve analysis. After a mean of 4.9 years follow-up, the CKD risk progression increased in parallel with the quartiles of baseline UACR <30 mg/g (p for trend <0.0001). UACR cutoff points of 8.44 mg/g overall, 10.59 mg/g in males and 8.15 mg/g in females were associated with the risk of CKD progression. In multivariate Cox regression analysis, the hazard ratios for the association between UACR (>8.44 mg/g, >10.9 mg/g, >8.15 mg/g in overall, male, and female patients, respectively) and the risk of CKD progression were significant. This study demonstrated that a cutoff UACR value of >10 mg/g could significantly predict the cumulative incidence and progression of CKD in patients with T2DM.
引用
收藏
页数:9
相关论文
共 50 条
  • [31] Association Between Urinary Sodium, Creatinine, Albumin, and Long-Term Survival in Chronic Kidney Disease
    McQuarrie, Emily P.
    Traynor, Jamie P.
    Taylor, Alison H.
    Freel, E. Marie
    Fox, Jonathan G.
    Jardine, Alan G.
    Mark, Patrick B.
    HYPERTENSION, 2014, 64 (01) : 111 - 117
  • [32] Prevalence of chronic kidney disease in patients with type 2 diabetes mellitus treated in primary care
    Lou Arnal, L. M.
    Campos Gutierrez, B.
    Cuberes Izquierdo, M.
    Gracia Garcia, O.
    Turon Alcaine, J. M.
    Bielsa Garcia, S.
    Gimeno Orna, J. A.
    Boned Juliani, B.
    Sanjuan Hernandez-French, A.
    NEFROLOGIA, 2010, 30 (05): : 552 - 556
  • [33] Urinary Albumin-to-Creatinine Ratio as a useful Risk Marker in patients with Cerebral Infarction
    Mao, Sen-Lin
    Luo, Sha
    Zhang, Ben-Ping
    Li, Feng
    Fu, Jin
    KUWAIT MEDICAL JOURNAL, 2018, 50 (04): : 455 - 460
  • [34] Assessing proteinuria in chronic kidney disease: protein-creatinine ratio versus albumin-creatinine ratio
    Methven, Shona
    MacGregor, Mark S.
    Traynor, Jamie P.
    O'Reilly, Denis St J.
    Deighan, Christopher J.
    NEPHROLOGY DIALYSIS TRANSPLANTATION, 2010, 25 (09) : 2991 - 2996
  • [35] Cost-effectiveness of screening type 2 diabetes patients for chronic kidney disease progression with the CKD273 urinary peptide classifier as compared to urinary albumin excretion
    Critselis, Elena
    Vlahou, Antonia
    Stel, Vianda S.
    Morton, Rachael L.
    NEPHROLOGY DIALYSIS TRANSPLANTATION, 2018, 33 (03) : 441 - 449
  • [36] Diabetic retinopathy is a prognostic factor for progression of chronic kidney disease in the patients with type 2 diabetes mellitus
    Park, Hayne Cho
    Lee, Young-Ki
    Cho, AJin
    Han, Chae Hoon
    Noh, Jung-Woo
    Shin, Young Joo
    Bae, So Hyun
    Kim, Hakyoung
    PLOS ONE, 2019, 14 (07):
  • [37] Treatment of type 2 diabetes mellitus in patients with chronic kidney disease
    Gomez-Huelgas, Ricardo
    Martinez-Castelao, Alberto
    Artola, Sara
    Gorriz, Jose Luis
    Menendez, Edelmiro
    MEDICINA CLINICA, 2014, 142 (02): : 85 - 85
  • [38] Medical Costs Associated with Severity of Chronic Kidney Disease in Type 2 Diabetes Mellitus in Singapore
    Lim, Gwyneth J.
    Liu, Yan Lun
    Low, Serena
    Ang, Keven
    Tavintharan, Subramaniam
    Sum, Chee Fang
    Lim, Su Chi
    ANNALS ACADEMY OF MEDICINE SINGAPORE, 2020, 49 (10) : 731 - 741
  • [39] Empagliflozin and Clinical Outcomes in Patients With Type 2 Diabetes Mellitus, Established Cardiovascular Disease, and Chronic Kidney Disease
    Wanner, Christoph
    Lachin, John M.
    Inzucchi, Silvio E.
    Fitchett, David
    Mattheus, Michaela
    George, Jyothis
    Woerle, Hans J.
    Broedl, Uli C.
    von Eynatten, Maximilian
    Zinman, Bernard
    Aizenberg, D.
    Ulla, M.
    Waitman, J.
    De Loredo, L.
    Farias, J.
    Fideleff, H.
    Lagrutta, M.
    Maldonado, N.
    Colombo, H.
    Ferre Pacora, F.
    Wasserman, A.
    Maffei, L.
    Lehman, R.
    Selvanayagam, J.
    d'Emden, M.
    Fasching, P.
    Paulweber, B.
    Toplak, H.
    Luger, A.
    Drexel, H.
    Prager, R.
    Schnack, C.
    Schernthaner, G.
    Fliesser-Goerzer, E.
    Kaser, S.
    Scheen, A.
    Van Gaal, L.
    Hollanders, G.
    Kockaerts, Y.
    Capiau, L.
    Chachati, A.
    Persu, A.
    Hermans, M.
    Vantroyen, D.
    Vercammen, C.
    Van de Borne, P.
    Mathieu, C.
    Benhalima, K.
    Lienart, F.
    Mortelmans, J.
    CIRCULATION, 2018, 137 (02) : 119 - 129
  • [40] Apparent Treatment Resistant Hypertension, Blood Pressure Control and the Progression of Chronic Kidney Disease in Patients with Type 2 Diabetes
    Viazzi, Francesca
    Greco, Eulalia
    Ceriello, Antonio
    Fioretto, Paola
    Giorda, Carlo
    Guida, Pietro
    Russo, Giuseppina
    De Cosmo, Salvatore
    Pontremoli, Roberto
    KIDNEY & BLOOD PRESSURE RESEARCH, 2018, 43 (02) : 422 - 438